The Potential of the Muscarinic System: Highlighting the Journey of KarXT Through Phase 1-3
Time: 3:20 pm
day: Conference Day 1 PM
Details:
- Evaluating the landscape of muscarinics in development for schizophrenia
- Explaining how the combination KarXT minimizes off-target muscarinic side effects in the clinic
- Outlining the factors that contributed to the strong results of the late phase trials
